Sordilla, Jessie .
HRN: 26-57-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/27/2025
02/03/2025
IVTT
600mg
Q8H
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes